ENTERA BIO LTD. Increase Decrease In Number Of Ordinary Shares Issued
ENTERA BIO LTD. (ENTX) reported Increase Decrease In Number Of Ordinary Shares Issued of 146.58 thousand shares for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Notes › Shares
ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued · last filed 2021-03-18
| Period end | Increase Decrease In Number Of Ordinary Shares Issued 12 month |
|---|---|
| 2020-12-31 | 146.58K shares 20-F · filed 2021-03-18 |
| 2018-12-31 | 27.95K shares 20-F · filed 2021-03-18 |
| 2016-12-31 | 2.28M shares 20-F · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |